Administration of CLS-TA in patients with noninfectious uveitis resulted in significant reductions in baseline retinal thickness, according to a press release from Clearside Biomedical, which outlined data from the PEACHTREE trial released at the American Society of Retina Specialists annual meeting in Vancouver, British Columbia.
At least 50% of patients in the CLS-TA arm of the trial had resolution of macular edema at every visit and were able to read at least 70 ETDRS letters, the release said. Eighty-five percent of patients in the treatment arm of the trial did (Read more...)
Uncategorized